Evidence map›Paper›PMID 33207822›Full record

ReviewAntioxidants (Basel, Switzerland)2020

Osteoprotective Roles of Green Tea Catechins.

Hsuan-Ti Huang, Tsung-Lin Cheng, Sung-Yen Lin, Cheng-Jung Ho, Joanna Y Chyu, Rong-Sen Yang, Chung-Hwan Chen, Chwan-Li Shen

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Ameliorating Effect ofMolecules (Basel, Switzerland) · 2025
    Article
  8. Article
  9. Extraction, Isolation and Purification of Catechins and their Applications.Medicinal chemistry (Shariqah (United Arab Emirates)) · 2025
    Review
  10. The Influence ofInternational journal of molecular sciences · 2024
    Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Isolation of Pro-Osteogenic Compounds fromInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Hsuan-Ti HuangOrthopaedic Research Center, Kaohsiung Medical University, Kaohsiung 80701, Taiwan.
Tsung-Lin ChengOrthopaedic Research Center, Kaohsiung Medical University, Kaohsiung 80701, Taiwan.ORCID 0000-0001-7080-8652
Sung-Yen LinOrthopaedic Research Center, Kaohsiung Medical University, Kaohsiung 80701, Taiwan.
Cheng-Jung HoOrthopaedic Research Center, Kaohsiung Medical University, Kaohsiung 80701, Taiwan.
Joanna Y ChyuSchool of Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA.
Rong-Sen YangDepartment of Orthopedics, National Taiwan University Hospital, Taipei 100229, Taiwan.ORCID 0000-0002-0553-4779
Chung-Hwan ChenOrthopaedic Research Center, Kaohsiung Medical University, Kaohsiung 80701, Taiwan.ORCID 0000-0001-8941-4792
Chwan-Li ShenDepartment of Pathology, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
Kaohsiung Medical University · TWNational Sun Yat-sen University · TWNational Taiwan University Hospital · TWTexas Tech University · USThe University of Texas Medical Branch at Galveston · US

Funding

Kaohsiung Medical University (KMU-TC108A02-1, NCTUKMU108-BIO-04, NPUST-KMU-109-P002 and KMU-DK10500Kaohsiung Medical University Hospital KMUH-107-7R54Kaohsiung Municipal Ta-Tung Hospital KMTTH107-26Minister of Science and Technology of Taiwan MOST 108-2314-B-037 -059 -MY3National Health Research Institute NHRI-EX101-9935EI
6 · The paper itself

Abstract

Osteoporosis is the second most common disease only secondary to cardiovascular disease, with the risk of fracture increasing with age. Osteoporosis is caused by an imbalance between osteoblastogenesis and osteoclastogenesis processes. Osteoclastogenesis may be enhanced, osteoblastogenesis may be reduced, or both may be evident. Inflammation and high reactive oxygen enhance osteoclastogenesis while reducing osteoblastogenesis by inducing osteoblast apoptosis and suppressing osteoblastic proliferation and differentiation. Catechins, the main polyphenols found in green tea with potent anti-oxidant and anti-inflammatory properties, can counteract the deleterious effects of the imbalance of osteoblastogenesis and osteoclastogenesis caused by osteoporosis. Green tea catechins can attenuate osteoclastogenesis by enhancing apoptosis of osteoclasts, hampering osteoclastogenesis, and prohibiting bone resorption in vitro. Catechin effects can be directly exerted on pre-osteoclasts/osteoclasts or indirectly exerted via the modulation of mesenchymal stem cells (MSCs)/stromal cell regulation of pre-osteoclasts through activation of the nuclear factor kB (RANK)/RANK ligand (RANKL)/osteoprotegerin (OPG) system. Catechins also can enhance osteoblastogenesis by enhancing osteogenic differentiation of MSCs and increasing osteoblastic survival, proliferation, differentiation, and mineralization. The in vitro effects of catechins on osteogenesis have been confirmed in several animal models, as well as in epidemiological observational studies on human subjects. Even though randomized control trials have not shown that catechins provide anti-fracture efficacy, safety data in the trials are promising. A large-scale, placebo-controlled, long-term randomized trial with a tea regimen intervention of optimal duration is required to determine anti-fracture efficacy.

Indexed as

antioxidantapoptosisgreen tea extractinflammationmesenchymal stem cellsosteoprotection

Identifiers

PMID33207822
PMCPMC7696448
OpenAlexW3102439258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.